Zimmer Biomet Holdings Inc Revenue Growth Rates (ZBH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Zimmer Biomet Holdings Inc   (NYSE: ZBH)
 

ZBH's Revenue Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZBH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2,177.00
1st Quarter March 2,086.70
FY 4,263.70

ZBHs Annual Revenue
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2025 $ 8,231.50 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2024 $ 7,678.60 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2023 $ 7,394.20 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2022 $ 6,939.90 millions
Zimmer Biomet Holdings Inc 's Revenue in the fiscal year 2021 $ 7,836.20 millions




ZBH Revenue second quarter 2026 Y/Y Growth Comment
Zimmer Biomet Holdings Inc reported Revenue growth of 4.8% year on year in the second quarter 2026, to $ 2,177.00 millions, this is lower than Zimmer Biomet Holdings Inc 's recent average Revenue growth of 5.07%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 137 other companies have achieved higher Revenue growth. While Zimmer Biomet Holdings Inc ' s Revenue increase of 4.8% ranks overall at the positon no. 2592 in the second quarter 2026.


ZBH Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 10.9 % 4.29 % 6.3 %
3rd Quarter September - 9.71 % 4.03 % 5.02 %
2nd Quarter June 4.8 % 6.97 % 3.87 % 4.93 %
1st Quarter March 9.3 % 1.05 % 3.18 % 10.09 %
FY   - 7.2 % 3.85 % -

Financial Statements
Zimmer Biomet Holdings Inc 's second quarter 2026 Revenue $ 2,177.00 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's second quarter 2025 Revenue $ 2,077.30 millions Quarterly ZBH's Income Statement


ZBH Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 12.11 % 10.91 % 10.63 %
3rd Quarter September - -3.65 % -6.07 % -6.2 %
2nd Quarter June 4.33 % 8.81 % 2.79 % 2.11 %
1st Quarter March -7 % -5.64 % -2.62 % 0.32 %
FY (Year on Year)   - 7.2 % 3.85 % -


Back to ZBH Growth rate Comparisons >> Back to ZBH Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #374
Overall #2592

Revenue Y/Y Growth Statistics
High Average Low
62.67 % 5.07 % -12 %
(Jun 30 2016)   (Dec 31 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #138
Healthcare Sector #374
Overall #2592
Revenue Y/Y Growth Statistics
High Average Low
62.67 % 5.07 % -12 %
(Jun 30 2016)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Zimmer Biomet Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
57.35 % 1.67 % -31.26 %
(Sep 30 2020)  


ZBH's II. Quarter Q/Q Revenue Comment
Zimmer Biomet Holdings Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.33%, to $ 2,177.00 millions, from $2,086.70 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1212.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #178
Overall #1212
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #50
Healthcare Sector #178
Overall #1212
Revenue Q/Q Growth Statistics
High Average Low
57.35 % 1.67 % -31.26 %
(Sep 30 2020)  


ZBH's II. Quarter Q/Q Revenue Comment
Zimmer Biomet Holdings Inc achieved in the II. Quarter 2026 above company average sequential Revenue growth of 4.33%, to $ 2,177.00 millions, from $2,086.70 millions in the first quarter.

Within Medical Equipment & Supplies industry 49 other companies have achieved higher Revenue quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1212.


Zimmer Biomet Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 8,508.80 $ 8,409.10 $ 8,231.50 $ 8,011.00 $ 7,833.80
Y / Y Revenue Growth (TTM) 8.62 % 9.23 % 7.2 % 5.47 % 4.11 %
Year on Year Revenue Growth Overall Ranking # 2262 # 1634 # 760 # 1732 # 1590
Seqeuential Revenue Change (TTM) 1.19 % 2.16 % 2.75 % 2.26 % 1.76 %
Seq. Revenue Growth (TTM) Overall Ranking # 2592 # 2436 # 910 # 2085 # 1989


Cumulative Revenue growth Comment
Assuming the Zimmer Biomet Holdings Inc 's fiscal year would have ended in Jun 30 2026, Zimmer Biomet Holdings Inc would have reprted above average annual Revenue improvement of 8.62% year on year, of $ 8,509 millions.
This marks a slow-down of the companys growth trends and from the 9.23% growth in Mar 31 2026.

In the Healthcare sector 329 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1634 to 2262.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 330
Overall # 2262

Revenue TTM Y/Y Growth Statistics
High Average Low
62.67 %
 5.07 %
-12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 374
S&P 500 # 2592
Cumulative Revenue growth Comment
Assuming the Zimmer Biomet Holdings Inc 's fiscal year would have ended in Jun 30 2026, Zimmer Biomet Holdings Inc would have reprted above average annual Revenue improvement of 8.62% year on year, of $ 8,509 millions.
This marks a slow-down of the companys growth trends and from the 9.23% growth in Mar 31 2026.

In the Healthcare sector 329 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1634 to 2262.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 330
Overall # 2262

Revenue TTM Y/Y Growth Statistics
High Average Low
62.67 %
5.07 %
-12 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 374
S&P 500 # 2592




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ZBH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Ocugen Inc 8.38%$ 8.376 millions
Baxter International Inc 8.36%$ 8.363 millions
Carlisle Companies Incorporated8.33%$ 8.334 millions
Universal Health Services Inc 8.27%$ 8.268 millions
Addus Homecare Corp8.18%$ 8.181 millions
Puma Biotechnology Inc 7.75%$ 7.754 millions
Cryoport inc 7.74%$ 7.737 millions
Schrodinger Inc 7.54%$ 7.542 millions
Boston Scientific Corporation7.53%$ 7.528 millions
Agilon Health Inc 7.15%$ 7.151 millions
Tenet Healthcare Corp6.77%$ 6.773 millions
Henry Schein Inc 6.73%$ 6.728 millions
Collegium Pharmaceutical Inc 6.67%$ 6.668 millions
Mallinckrodt Plc6.62%$ 6.617 millions
Johnson and Johnson6.60%$ 6.600 millions
Prestige Consumer Healthcare Inc 6.57%$ 6.569 millions
Msa Safety Inc6.25%$ 6.252 millions
Pacira Biosciences inc 6.24%$ 6.240 millions
Globus Medical Inc 5.94%$ 5.940 millions
Labcorp Holdings Inc 5.78%$ 5.778 millions
Tandem Diabetes Care Inc 5.77%$ 5.768 millions
Bristol myers Squibb Company5.74%$ 5.738 millions
Haemonetics Corporation5.65%$ 5.646 millions
Progyny Inc 5.58%$ 5.584 millions
Cytek Biosciences Inc 5.57%$ 5.566 millions
Amphastar Pharmaceuticals Inc 5.44%$ 5.441 millions
Becton Dickinson And Company5.44%$ 5.438 millions
Bruker Corporation5.22%$ 5.220 millions
Davita Inc 5.17%$ 5.165 millions
Park Dental Partners Inc 5.10%$ 5.102 millions


About Zimmer Biomet Holdings Inc Revenue Growth Rates (ZBH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Zimmer Biomet Holdings Inc (CIK 1136869).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-335044
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Zimmer Biomet Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.